Income Statement Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
7.210 ^USD	-1.23%		+1.69%	-47.41%

Nov. 26	Sector Update: Health Care Stocks Edge Higher Premarket Wednesday	MT
Nov. 25	Myriad Genetics Collaborates With Clairity, MagView to Roll Out AI Platform for Breast Cancer Risk Assessment	MT

fe1a6fac31604dbf6fa7692970b.GoeKnA6aXtbT4bUslsTp1nmdAIMINUzXoxv4eMPCmsM.dMzL5kqoLLGR0YxloqqYsx7XdfVgWXq6z2HICLOJ-IhUzPLed-4urrLT4A

Published financial data: MYRIAD GENETICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	600M	691M	678M	753M	838M
Total Revenues	600M	691M	678M	753M	838M
Cost of Goods Sold, Total	183M	198M	202M	236M	252M
Gross Profit	417M	493M	476M	517M	585M
Selling General & Admin Expenses, Total	514M	538M	515M	567M	560M
R&D Expenses	71.6M	81.9M	85.4M	88.7M	113M
Other Operating Expenses, Total	585M	620M	600M	656M	673M
Operating Income	-169M	-127M	-124M	-139M	-88M
Interest Expense, Total	-11.6M	-6.6M	-3.2M	-2.9M	-2.8M
Interest And Investment Income	1.4M	700K	2.6M	2.5M	1.7M
Net Interest Expenses	-10.2M	-5.9M	-600K	-400K	-1.1M
Currency Exchange Gains (Loss)	-	-	-	-3.4M	-1.1M
Other Non Operating Income (Expenses)	-2.4M	-600K	600K	500K	2.2M
EBT, Excl. Unusual Items	-181M	-133M	-124M	-142M	-88M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-82M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-1.5M	-
Gain (Loss) On Sale Of Assets	1M	152M	-	-	-12.4M
Asset Writedown	-17.7M	-1.8M	-16.9M	-5.7M	-44.4M
Legal Settlements	-	-62M	-	-113M	21.3M
Other Unusual Items	-7M	-11.7M	-	-	-
EBT, Incl. Unusual Items	-188M	-57.1M	-141M	-262M	-124M
Income Tax Expense	-82M	-29.9M	-28.6M	1.1M	3.8M
Earnings From Continuing Operations	-106M	-27.2M	-112M	-263M	-127M
Net Income to Company	-106M	-27.2M	-112M	-263M	-127M
Minority Interest	100K	-	-	-	-
Net Income - (IS)	-106M	-27.2M	-112M	-263M	-127M
Net Income to Common Incl Extra Items	-106M	-27.2M	-112M	-263M	-127M
Net Income to Common Excl. Extra Items	-106M	-27.2M	-112M	-263M	-127M
Per Share Items
Net EPS - Basic	-1.42	-0.35	-1.39	-3.18	-1.41
Basic EPS - Continuing Operations	-1.42	-0.35	-1.39	-3.18	-1.41
Basic Weighted Average Shares Outstanding	75M	78M	80.6M	82.8M	90.6M
Net EPS - Diluted	-1.42	-0.35	-1.39	-3.18	-1.41
Diluted EPS - Continuing Operations	-1.42	-0.35	-1.39	-3.18	-1.41
Diluted Weighted Average Shares Outstanding	75M	78M	80.6M	82.8M	90.6M
Normalized Basic EPS	-1.51	-1.07	-0.96	-1.07	-0.61
Normalized Diluted EPS	-1.51	-1.07	-0.96	-1.07	-0.61
Supplemental Items
EBITDA	-97M	-63.9M	-71M	-82.7M	-26.8M
EBITA	-107M	-76M	-82.6M	-96.1M	-45.9M
EBIT	-169M	-127M	-124M	-139M	-88M
EBITDAR	-38.6M	-43.2M	-	-56.8M	-5.8M
Total Revenues (As Reported)	600M	691M	678M	753M	-
Effective Tax Rate - (Ratio)	43.57	52.36	20.34	-0.42	-3.08
Current Domestic Taxes	-153M	1.7M	1.4M	5.2M	4.9M
Current Foreign Taxes	400K	100K	500K	200K	1.2M
Total Current Taxes	-152M	1.8M	1.9M	5.4M	6.1M
Deferred Domestic Taxes	71.4M	-	-	-	-
Deferred Foreign Taxes	-1M	-	-	-	-
Total Deferred Taxes	70.4M	-31.7M	-30.9M	-4.3M	-2.3M
Normalized Net Income	-113M	-83.25M	-77.31M	-88.88M	-55M
Interest on Long-Term Debt	5.8M	6.6M	3.2M	2.9M	2.8M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	10.3M
Selling and Marketing Expenses	-	-	-	-	284M
General and Administrative Expenses	-	-	-	-	276M
Research And Development Expense From Footnotes	71.6M	81.9M	85.4M	88.7M	113M
Net Rental Expense, Total	9.9M	20.7M	-	25.9M	21M
Imputed Operating Lease Interest Expense	6.02M	5.73M	-	4.04M	3.22M
Imputed Operating Lease Depreciation	12.38M	14.97M	-	21.86M	17.78M
Stock-Based Comp., COGS (Total)	1.4M	1.6M	1.7M	1.4M	1.6M
Stock-Based Comp., R&D Exp. (Total)	4.8M	4.2M	5.2M	4M	8.8M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	-	9M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	30.4M
Stock-Based Comp., SG&A Exp. (Total)	23.6M	30.5M	31.2M	35.3M	-
Total Stock-Based Compensation	29.8M	36.3M	38.1M	40.7M	49.8M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	117M	258M	56.9M	132M	102M
Short Term Investments	33.7M	81.4M	58M	8.8M	-
Total Cash And Short Term Investments	151M	340M	115M	141M	102M
Accounts Receivable, Total	89.5M	91.3M	102M	114M	121M
Other Receivables	2M	-	-	-	-
Total Receivables	91.5M	91.3M	102M	114M	121M
Inventory	27.1M	15.3M	20.1M	22M	27.5M
Prepaid Expenses	120M	38.4M	38M	35.2M	38.3M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	-	-	-	1.2M	8.6M
Total Current Assets	389M	485M	275M	314M	298M
Gross Property Plant And Equipment	213M	232M	296M	300M	282M
Accumulated Depreciation	-113M	-107M	-109M	-120M	-110M
Net Property Plant And Equipment	100M	125M	187M	181M	172M
Long-term Investments	21M	59M	54.8M	-	-
Goodwill	329M	239M	287M	287M	286M
Other Intangibles, Total	576M	411M	387M	354M	266M
Other Long-Term Assets, Total	2.3M	1.6M	8.4M	10.8M	5.1M
Total Assets	1.42B	1.32B	1.2B	1.15B	1.03B
Liabilities
Accounts Payable, Total	20.5M	29.6M	28.8M	25.8M	32.3M
Accrued Expenses, Total	62.1M	77.5M	70.2M	75.7M	79.9M
Current Portion of Leases	13.6M	13M	14.1M	16.2M	12.8M
Current Income Taxes Payable	4.3M	4M	4.8M	4.6M	5.1M
Unearned Revenue Current, Total	32.7M	5.2M	-	-	-
Other Current Liabilities	12.7M	75M	19.3M	33.6M	34M
Total Current Liabilities	146M	204M	137M	156M	164M
Long-Term Debt	225M	-	-	38.5M	39.6M
Long-Term Leases	50.6M	79.3M	131M	97.4M	87.9M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	71.3M	35.8M	3.5M	-	-
Other Non Current Liabilities	45.2M	33.5M	41.3M	71.5M	34.9M
Total Liabilities	538M	353M	313M	363M	326M
Common Stock, Total	800K	800K	800K	900K	900K
Additional Paid In Capital	1.11B	1.23B	1.26B	1.42B	1.46B
Retained Earnings	-227M	-254M	-366M	-630M	-757M
Comprehensive Income and Other	-2.3M	-5.1M	-8.9M	-3.7M	-800K
Total Common Equity	881M	968M	886M	783M	701M
Minority Interest	-	-	-	-	-
Total Equity	881M	968M	886M	783M	701M
Total Liabilities And Equity	1.42B	1.32B	1.2B	1.15B	1.03B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	76.3M	80.02M	81.22M	89.87M	91.31M
ECS Total Common Shares Outstanding	75.4M	80M	81.2M	89.9M	91.3M
Book Value / Share	11.68	12.1	10.91	8.71	7.68
Tangible Book Value	-24.7M	318M	212M	142M	149M
Tangible Book Value Per Share	-0.33	3.97	2.61	1.58	1.63
Total Debt	289M	92.3M	145M	152M	140M
Net Debt	117M	-306M	-24.7M	11.2M	37.9M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	-	-	-
Debt Equivalent Oper. Leases	147M	166M	-	207M	168M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	27.1M	15.3M	20.1M	22M	27.5M
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	118M	112M	125M	148M	148M
Full Time Employees	2.7K	2.4K	2.6K	2.7K	2.7K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-106M	-27.2M	-112M	-263M	-127M
Depreciation & Amortization - CF	10M	12.1M	11.6M	13.4M	19.1M
Amortization of Goodwill and Intangible Assets - (CF)	61.6M	50.7M	41.1M	42.8M	42.1M
Depreciation & Amortization, Total	71.6M	62.8M	52.7M	56.2M	61.2M
(Gain) Loss From Sale Of Asset	-200K	-162M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	1.5M	-
Asset Writedown & Restructuring Costs	99.7M	1.8M	16.9M	5.7M	56.6M
Stock-Based Compensation (CF)	29.8M	36.3M	38.1M	40.7M	49.8M
Tax Benefit from Stock Options	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	121M	-13.9M	-500K	21.3M	5.4M
Change In Accounts Receivable	-42.8M	-8.8M	-10.3M	-12.5M	-8.7M
Change In Inventories	4.4M	1.6M	-2.9M	-1.8M	-6.2M
Change In Accounts Payable	-2.4M	9.2M	-3.5M	-3.7M	4.7M
Change in Unearned Revenues	-400K	-26.6M	-5M	-200K	-
Change In Income Taxes	-217M	89.9M	700K	700K	500K
Change in Other Net Operating Assets	-5.6M	55.1M	-80.5M	44.5M	-44.7M
Cash from Operations	-147M	18.2M	-106M	-111M	-8.7M
Capital Expenditure	-15.8M	-18M	-45.3M	-63.2M	-19M
Cash Acquisitions	-	-	-57.2M	-	-
Divestitures	21.3M	379M	-	-	8.8M
Sale (Purchase) of Intangible assets	-	-	-	-10.1M	-10.7M
Investment in Marketable and Equity Securities, Total	71.8M	-86.7M	25M	105M	9M
Cash from Investing	56M	274M	-77.5M	31.9M	-11.9M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	80M	120M
Total Debt Issued	-	-	-	80M	120M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-8.6M	-226M	-	-40.2M	-120M
Total Debt Repaid	-8.6M	-226M	-	-40.2M	-120M
Issuance of Common Stock	3.6M	91.8M	6.3M	6M	5.9M
Repurchase of Common Stock	-7.6M	-11.5M	-10.6M	-8.8M	-13.4M
Other Financing Activities, Total	-200K	-4.5M	-3.7M	116M	-
Cash from Financing	-4.2M	-151M	-8M	153M	-7.4M
Foreign Exchange Rate Adjustments	2.2M	-600K	-600K	600K	-1M
Net Change in Cash	-93.4M	141M	-192M	74.5M	-29M
Supplemental Items
Cash Interest Paid	10.4M	4.4M	-	1.4M	1.9M
Cash Income Tax Paid (Refund)	3.6M	-85.4M	1.8M	1.9M	2.7M
Levered Free Cash Flow	110M	150M	-116M	-61.42M	13.25M
Unlevered Free Cash Flow	116M	155M	-114M	-59.61M	15M
Change In Net Working Capital	-114M	-153M	81.9M	-3.6M	11.3M
Net Debt Issued / Repaid	-8.6M	-226M	-	39.8M	100K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-5.68	-5.78	-6.14	-7.4	-5.06
Return on Total Capital	-6.65	-7.1	-7.4	-8.83	-6.19
Return On Equity %	-19.89	-2.94	-12.08	-31.55	-17.15
Return on Common Equity	-19.88	-2.94	-12.08	-31.55	-17.15
Margin Analysis
Gross Profit Margin %	69.51	71.39	70.22	68.64	69.89
SG&A Margin	85.69	77.87	75.87	75.31	66.86
EBITDA Margin %	-16.18	-9.25	-10.47	-10.98	-3.2
EBITA Margin %	-17.85	-11	-12.18	-12.76	-5.48
EBIT Margin %	-28.12	-18.35	-18.23	-18.44	-10.51
Income From Continuing Operations Margin %	-17.71	-3.94	-16.51	-34.96	-15.2
Net Income Margin %	-17.71	-3.94	-16.51	-34.96	-15.2
Net Avail. For Common Margin %	-17.71	-3.94	-16.51	-34.96	-15.2
Normalized Net Income Margin	-18.89	-12.05	-11.4	-11.8	-6.57
Levered Free Cash Flow Margin	17.15	21.79	-17.06	-8.16	1.58
Unlevered Free Cash Flow Margin	18.2	22.39	-16.76	-7.91	1.79
Asset Turnover
Asset Turnover	0.43	0.5	0.54	0.64	0.77
Fixed Assets Turnover	7.97	6.12	4.34	4.09	4.75
Receivables Turnover (Average Receivables)	6.32	7.64	7.03	6.98	7.11
Inventory Turnover (Average Inventory)	6.15	9.32	11.41	11.22	10.19
Short Term Liquidity
Current Ratio	2.67	2.37	2	2.01	1.82
Quick Ratio	1.66	2.11	1.58	1.64	1.36
Operating Cash Flow to Current Liabilities	-1.01	0.09	-0.77	-0.71	-0.05
Days Sales Outstanding (Average Receivables)	57.89	47.78	51.89	52.31	51.45
Days Outstanding Inventory (Average Inventory)	59.49	39.16	31.98	32.53	35.92
Average Days Payable Outstanding	54.76	49.21	51.54	41.85	41.26
Cash Conversion Cycle (Average Days)	62.62	37.73	32.34	42.99	46.11
Long Term Solvency
Total Debt/Equity	32.8	9.54	16.37	19.42	20.01
Total Debt / Total Capital	24.7	8.71	14.07	16.26	16.67
LT Debt/Equity	31.26	8.19	14.78	17.35	18.19
Long-Term Debt / Total Capital	23.54	7.48	12.7	14.53	15.15
Total Liabilities / Total Assets	37.91	26.72	26.1	31.69	31.77
EBIT / Interest Expense	-14.53	-19.2	-38.66	-47.9	-31.43
EBITDA / Interest Expense	-8.36	-6.55	-15.72	-19.59	-2.07
(EBITDA - Capex) / Interest Expense	-9.72	-9.27	-29.88	-41.38	-8.86
Total Debt / EBITDA	-2.98	-2.14	-2.88	-2.68	-24.19
Net Debt / EBITDA	-1.21	7.09	0.49	-0.2	-6.53
Total Debt / (EBITDA - Capex)	-2.56	-1.51	-1.52	-1.27	-5.66
Net Debt / (EBITDA - Capex)	-1.04	5.01	0.26	-0.09	-1.53
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-24.97	23.99	-1.77	11.03	11.21
Gross Profit, 1 Yr. Growth %	-30.4	30.15	-3.37	8.52	13.23
EBITDA, 1 Yr. Growth %	-161.27	-48.22	11.11	-0.36	-67.59
EBITA, 1 Yr. Growth %	-183.11	-43.07	8.68	1.59	-52.24
EBIT, 1 Yr. Growth %	-556.95	-34.96	-2.37	2.36	-36.65
Earnings From Cont. Operations, 1 Yr. Growth %	-4.64K	-87.85	311.76	135.09	-51.65
Net Income, 1 Yr. Growth %	-4.44K	-87.84	311.76	135.09	-51.65
Normalized Net Income, 1 Yr. Growth %	-738.34	-29.35	-7.13	4.79	-38.12
Diluted EPS Before Extra, 1 Yr. Growth %	-4.58K	-88.31	297.14	128.78	-55.66
Accounts Receivable, 1 Yr. Growth %	-49.14	2.01	11.28	12.5	6.04
Inventory, 1 Yr. Growth %	-7.32	-43.54	31.37	9.45	25
Net Property, Plant and Equip., 1 Yr. Growth %	79.76	24.8	49.48	-3.58	-4.54
Total Assets, 1 Yr. Growth %	-10.12	-6.91	-9.24	-4.35	-10.37
Tangible Book Value, 1 Yr. Growth %	13.08	-1.28K	-33.23	-33.22	5.15
Common Equity, 1 Yr. Growth %	-15.68	9.85	-8.47	-11.58	-10.48
Cash From Operations, 1 Yr. Growth %	-27.48	-167.66	-671.51	4.33	-92.16
Capital Expenditures, 1 Yr. Growth %	18.6	36.36	151.67	39.51	-69.94
Levered Free Cash Flow, 1 Yr. Growth %	83.3	-	-177.41	-50.15	-121.57
Unlevered Free Cash Flow, 1 Yr. Growth %	72.89	-	-174.03	-50.82	-125.16
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-7.34	-	10.36	4.43	11.12
Gross Profit, 2 Yr. CAGR %	-10.63	-	12.15	2.41	10.85
EBITDA, 2 Yr. CAGR %	-26.13	-	-24.15	13.76	-38.56
EBITA, 2 Yr. CAGR %	-13.22	-	-21.34	12.45	-25.46
EBIT, 2 Yr. CAGR %	49.02	-	-20.31	4.7	-15.66
Earnings From Cont. Operations, 2 Yr. CAGR %	22.46	-	-29.26	211.13	6.61
Net Income, 2 Yr. CAGR %	22.34	-	-29.24	211.13	6.61
Normalized Net Income, 2 Yr. CAGR %	54.76	-	-19	3.32	-15.66
Diluted EPS Before Extra, 2 Yr. CAGR %	20.58	-	-31.87	201.43	0.72
Accounts Receivable, 2 Yr. CAGR %	-17.27	-	6.55	11.89	9.22
Inventory, 2 Yr. CAGR %	-7.89	-	-13.88	19.91	16.97
Net Property, Plant and Equip., 2 Yr. CAGR %	54.41	-	36.58	20.06	-4.06
Total Assets, 2 Yr. CAGR %	9.32	-	-8.08	-6.83	-7.41
Tangible Book Value, 2 Yr. CAGR %	-72.35	-	180.34	-33.23	-16.2
Common Equity, 2 Yr. CAGR %	-2.51	-	0.27	-10.04	-11.03
Cash From Operations, 2 Yr. CAGR %	-27.63	-	98.79	144.18	-71.39
Capital Expenditures, 2 Yr. CAGR %	10.19	-	85.25	87.38	-35.24
Levered Free Cash Flow, 2 Yr. CAGR %	595.69	-	-	-35.9	-66.16
Unlevered Free Cash Flow, 2 Yr. CAGR %	2K	-	-	-37.7	-63.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4.3	-	-	10.58	6.64
Gross Profit, 3 Yr. CAGR %	-6.72	-	-	10.92	5.89
EBITDA, 3 Yr. CAGR %	-11.79	-	-	-12.49	-25.15
EBITA, 3 Yr. CAGR %	-1.19	-	-	-10.38	-15.47
EBIT, 3 Yr. CAGR %	46.13	-	-	-10.66	-11.44
Earnings From Cont. Operations, 3 Yr. CAGR %	126.4	-	-	5.57	67.27
Net Income, 3 Yr. CAGR %	125.49	-	-	5.58	67.27
Normalized Net Income, 3 Yr. CAGR %	52.09	-	-	-8.97	-12.91
Diluted EPS Before Extra, 3 Yr. CAGR %	120.77	-	-	2.02	59.12
Accounts Receivable, 3 Yr. CAGR %	-8.94	-	-	8.49	9.9
Inventory, 3 Yr. CAGR %	-11.65	-	-	-6.71	21.59
Net Property, Plant and Equip., 3 Yr. CAGR %	26.32	-	-	21.62	11.22
Total Assets, 3 Yr. CAGR %	5.13	-	-	-6.86	-8.02
Tangible Book Value, 3 Yr. CAGR %	-27.89	-	-	73.78	-22.31
Common Equity, 3 Yr. CAGR %	6.12	-	-	-3.85	-10.19
Cash From Operations, 3 Yr. CAGR %	-17.01	-	-	60.35	-22.38
Capital Expenditures, 3 Yr. CAGR %	18.69	-	-	68.54	1.82
Levered Free Cash Flow, 3 Yr. CAGR %	-23.55	-	-	-	-55.41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-22.4	-	-	-	-53.95
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.45	-	-	-	-
Gross Profit, 5 Yr. CAGR %	-4.7	-	-	-	-
EBITDA, 5 Yr. CAGR %	-16.98	-	-	-	-
EBITA, 5 Yr. CAGR %	-12.86	-	-	-	-
EBIT, 5 Yr. CAGR %	0.09	-	-	-	-
Earnings From Cont. Operations, 5 Yr. CAGR %	20	-	-	-	-
Net Income, 5 Yr. CAGR %	19.99	-	-	-	-
Normalized Net Income, 5 Yr. CAGR %	0.93	-	-	-	-
Diluted EPS Before Extra, 5 Yr. CAGR %	20.02	-	-	-	-
Accounts Receivable, 5 Yr. CAGR %	-4.52	-	-	-	-
Inventory, 5 Yr. CAGR %	3	-	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	8.92	-	-	-	-
Total Assets, 5 Yr. CAGR %	12.89	-	-	-	-
Tangible Book Value, 5 Yr. CAGR %	-45.01	-	-	-	-
Common Equity, 5 Yr. CAGR %	6.76	-	-	-	-
Cash From Operations, 5 Yr. CAGR %	-15.45	-	-	-	-
Capital Expenditures, 5 Yr. CAGR %	-15.66	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-1.12	-	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.05	-	-	-	-